We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QUB:ASXQube Holdings Ltd. Analysis

Data as of 2026-06-13 - not real-time

A$5.07

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Qube Holdings is trading at AUD 5.07, just above the computed support of 4.98 and below the resistance of 5.13. The 20‑day SMA (5.02) sits marginally above the 50‑day SMA (5.01) and both are comfortably higher than the 200‑day SMA (4.69), indicating a bullish price structure. Momentum indicators reinforce this view: the RSI is at 63.6, the MACD line is positive (0.012) and above its signal (0.006), and volume is on an increasing trend. Beta is very low (≈0.20) and 30‑day volatility is modest at 5.3%, suggesting limited price swings, while the Fear & Greed Index reads “Extreme Greed” at 89.9, reflecting strong market optimism.
Fundamentally, the stock appears stretched: a trailing P/E of 42.3 far exceeds the industry average of 30.6, and the discounted cash‑flow fair value (≈AUD 1.85) is less than half the current price, yielding a negative upside/downside of –0.8%. Revenue is growing at 10.2% YoY, yet margins remain thin (gross 19.8%, operating 9.9%, profit 3.6%) and leverage is high with a debt‑to‑equity of 98.3. The dividend yield of 2.18% is backed by a payout ratio of 78.8%, which may be unsustainable given the debt load. A takeover offer from Macquarie at AUD 5.20 per share creates a 3.5% discount to the offer price, adding a short‑term catalyst but also highlighting valuation concerns.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Bullish technical alignment (SMA crossover, MACD, RSI)
  • Takeover premium creates a 3.5% discount to offer price
  • Increasing volume supporting upward momentum

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Uncertainty around deal completion and potential regulatory approval
  • High valuation relative to earnings and DCF
  • Strong cash flow currently covering dividend despite leverage

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Significant overvaluation (PE 42x vs industry 30x, DCF far below market)
  • Elevated debt‑to‑equity ratio limiting financial flexibility
  • Thin profit margins and modest ROE (7%) constrain sustainable growth

Key Metrics & Analysis

Financial Health

Revenue Growth10.20%
Profit Margin3.62%
P/E Ratio42.3
ROE6.98%
ROA2.69%
Debt/Equity98.28
P/B Ratio2.9
Op. Cash FlowA$516.5M
Free Cash FlowA$306.4M
Industry P/E30.6

Technical Analysis

TrendBullish
RSI63.6
SupportA$4.98
ResistanceA$5.13
MA 20A$5.02
MA 50A$5.01
MA 200A$4.69
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueA$1.85
Target PriceA$5.03
Upside/Downside-0.79%
GradeOvervalued
TypeGrowth
Dividend Yield2.18%

Risk Assessment

Beta0.20
Volatility5.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.